Physicians' Knowledge About FDA Approval Standards and Perceptions of the "Breakthrough Therapy" Designation

JAMA. 2016 Apr 12;315(14):1516-8. doi: 10.1001/jama.2015.16984.

Authors

Aaron S Kesselheim¹, Steven Woloshin², Wesley Eddings¹, Jessica M Franklin¹, Kathryn M Ross³, Lisa M Schwartz²

Affiliations

¹ Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, Massachusetts.
² Center for Medicine and the Media, Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, New Hampshire3Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire.
³ American Board of Internal Medicine, Philadelphia, Pennsylvania.

PMID: 27115269
DOI: 10.1001/jama.2015.16984

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Confidence Intervals
Diffusion of Innovation*
Drug Approval / methods*
Female
Health Knowledge, Attitudes, Practice*
Humans
Internal Medicine / statistics & numerical data
Male
Middle Aged
Physicians*
Specialization / statistics & numerical data
Surveys and Questionnaires*
United States
United States Food and Drug Administration*